Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone ...

Retrieved on: 2025-04-15 13:20:56

Tags for this article:

Click the tags to see associated articles and topics

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone .... View article details on hiswai:

Excerpt

JERUSALEM, April 15, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. NASDAQ:ENTX, a leader in the development of oral peptides and proteins replacement ...

Article found on: www.tradingview.com